Corecruitment of the Grg4 repressor by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes

EMBO Reports

Volumn 5, Issue 3, 2004, Pages 291-296

  Linderson, Ylva ^a   Eberhard, Dirk ^a,b,c   Malin, Stephen ^a   Johansson, Annica ^a   Busslinger, Meinrad ^b   Pettersson, Sven ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

B cell; Grg4; Pax5; PU.1

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN GRG4; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL SPECIFICITY; CONTROLLED STUDY; DATA ANALYSIS; ENHANCER REGION; GENE FUNCTION; GENE REPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ANIMALS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; DOWN-REGULATION; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; GENES, IMMUNOGLOBULIN; GENES, REPORTER; GLOBINS; HUMANS; IMMUNOGLOBULIN J-CHAINS; LUCIFERASES; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 16544393313     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.7400089     Document Type: Article

References (24)

1. Andersson T, Neurath MF, Grant PA, Pettersson S (1996) Physiological activation of the IgH 3′ enhancer in B lineage cells is not blocked by Pax5. Eur J Immunol 26: 2499-2507
2. Arulampalam V, Eckhardt L, Pettersson S (1997) The enhancer shift: a model to explain the developmental control of IgH gene expression in B-lineage cells. Immunol Today 18: 549-554
3. Brantjes H, Roose J, van De Wetering M, Clevers H (2001) All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res 29: 1410-1419
4. Czerny T, Busslinger M (1995) DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5). Mol Cell Biol 15: 2858-2871
5. Eberhard D, Jimenez G, Heavey B, Busslinger M (2000) Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J 19: 2292-2303
6. Lamson G, Koshland ME (1984) Changes in J chain and mu chain RNA expression as a function of B cell differentiation. J Exp Med 160: 877-892
7. Linderson Y, French NS, Neurath MF, Pettersson S (2001) Context-dependent Pax-5 repression of a PU.1/NF-κB regulated reporter gene in B lineage cells. Gene 262: 107-114
8. Liu X, Prabhu A, van Ness B (1999) Developmental regulation of the kappa locus involves both positive and negative sequence elements in the 3′ enhancer that affect synergy with the intron enhancer. J Biol Chem 274: 3285-3293
9. Maitra S, Atchison M (2000) BSAP can repress enhancer activity by targeting PU.1 function. Mol Cell Biol 20: 1911-1922
10. Mikkola I, Heavey B, Horcher M, Busslinger M (2002) Reversion of B cell commitment upon loss of Pax5 expression. Nature 297: 110-113
11. Neurath MF, Max EE, Strober W (1995) Pax5 (BSAP) regulates the murine immunoglobulin 3′ α enhancer by suppressing binding of NF-α P, a protein that controls heavy chain transcription. Proc Natl Acad Sci USA 92: 5336-5340
12. Ren B, Chee KJ, Kim TH, Maniatis T (1999) PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev 13:125-137
13. Roque MC, Smith PA, Blasquez VC (1996) A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3′ echancer. Mol Cell Biol 16: 3138-3155
14. Schebesta M, Heavey B, Busslinger M (2002) Transcriptional control of B-cell development. Curr Opin Immunol 14: 216-223
15. Scott EW, Simon MC, Anastasi J, Singh H (1994) Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265: 1573-1577
16. Shaffer AL, Peng A, Schlissel MS (1997) In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation. Immunity 6: 131-143
17. Sigvardsson M, Olsson L, Högbom E, Leanderson T (1993) Characterization of the joining chain (J-chain) promoter. Scand J Immunol 38: 411-416
18. Singh M, Birshtein BK (1996) Concerted repression of an immunoglobulin heavychain enhancer, 3′ α E(hs1,2). Proc Natl Acad Sci USA 93: 4392-4397
19. Stifani S, Blaumueller CM, Redhead NJ, Hill RE, Artavanis-Tsakonas S (1992) Human homologs of a Drosophila enhancer of split gene product define a novel family of nuclear proteins. Nat Genet 2: 119-127
20. Tetsuka T, Uranishi H, Imai H, Ono T, Sonta S, Takahashi N, Asamitsu K, Okamoto T (2000) Inhibition of nuclear factor-κ B-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeats. J Biol Chem 275: 4383-4390
21. Thompson CB et al (1992) cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol Cell Biol 12: 1043-1053
22. Underhill GH, George D, Bremer EG, Kansas GS (2003) Gene expression profiling reveals a highly specialized genetic program of plasma cells. Blood 101: 4013-4021
23. Urbánek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M (1994) Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79: 901-912
24. Valentine SA, Chen G, Shandala T, Fernandez J, Mische S, Saint R, Courey AJ (1998) Dorsal-mediated repression requires the formation of a multiprotein repression complex at the ventral silencer. Mol Cell Biol 18: 6584-6594